Skip to main content
. 2022 Oct 11;10(5):2038–2048. doi: 10.1016/j.gendis.2022.10.001

Figure 5.

Fig. 5

NK2.1/2 expression in cancer. Illustration summarizes NK2.1 and NK2.2 involvement in cancer, together with data regarding diagnostic and/or prognostic potential as cancer markers. AML: acute myeloid leukemia; BC: breast cancer; CRC: colorectal cancer; DLBCL: diffuse large B cell lymphoma; GBM: glioblastoma; GC: gastric cancer; HCC: hepatocellular carcinoma; HNSCCs: head and neck squamous cell carcinomas; NSCLC: non-small cell lung cancer; PTC: papillary thyroid cancer; SCLC: small cell lung cancer; T-ALL: T-cell acute lymphoblastic leukemia. Created with Biorender.com.